Patients | |||
---|---|---|---|
Variable | Value | N | % |
Gender | Male | 77 | 57.0 |
Female | 58 | 43.0 | |
Age (years) | < 65 | 57 | 42.2 |
65+ | 78 | 57.8 | |
Min – Max | 29–94 | ||
Mean ± standard deviation | 66.8 ± 12.7 | ||
Education | Reads and writes | 5 | 3.7 |
4 years | 81 | 60.0 | |
6 years | 20 | 14.8 | |
9 years | 10 | 7.4 | |
10 years to college | 19 | 14.0 | |
Geographical Region | North | 74 | 54.8 |
Centre | 25 | 18.5 | |
South | 36 | 26.7 | |
Area | Urban | 94 | 69.6 |
Peri-urban | 31 | 23.0 | |
Rural | 10 | 7.4 | |
Place of care | Primary care | 28 | 20.7 |
Hospital | 25 | 18.5 | |
Palliative care | 82 | 60.7 | |
Cancer diagnosis | Yes | 109 | 80.7 |
No | 26 | 19.3 | |
Life expectancy | Less than 6 months | 48 | 35.6 |
Between 6 months and 1 year | 47 | 34.8 | |
More than 1 year | 40 | 29.6 | |
Phase of illness | Stable | 64 | 47.4 |
Unstable | 28 | 20.7 | |
Deteriorating | 43 | 31.9 | |
Quality of Life | Mean Index | 31.4 | |
Mean VAS | 53.7 | ||
Anxiety (HADS) | Normal (0–7) | 11 | 8.1 |
Mild (8–10) | 16 | 11.9 | |
Moderate (11–14) | 66 | 48.9 | |
Severe (15–21) | 42 | 31.1 | |
Mean ± standard deviation | 12.7 ± 3.1 | ||
Depression (HADS) | Normal (0–7) | 17 | 12.6 |
Mild (8–10) | 63 | 46.7 | |
Moderate (11–14) | 48 | 35.6 | |
Severe (15–21) | 7 | 5.2 | |
Mean ± standard deviation | 10.1 ± 2.6 | ||
EORTC Quality of Life | 49.7 ± 20.6 | ||
EORTC Functional scales | Physical functioning | 48.4 ± 28.7 | |
Role functioning | 51.5 ± 34.7 | ||
Emotional functioning | 62.5 ± 24.2 | ||
Cognitive functioning | 75.4 ± 23.2 | ||
Social functioning | 66.9 ± 30.9 | ||
EORTC Symptom scales | Fatigue | 49.0 ± 25.4 | |
Nausea and vomiting | 8.1 ± 16.5 | ||
Pain | 35.1 ± 29.1 | ||
Dyspnoea | 14.1 ± 26.5 | ||
Insomnia | 32.6 ± 34.4 | ||
Appetite loss | 30.9 ± 36.6 | ||
Constipation | 24.9 ± 31.7 | ||
Diarrhoea | 9.1 ± 20.9 | ||
Financial impact | 32.6 ± 35.8 |